THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug. viable cell number was counted, the number decreased remarkably, then increasedrapidly number as the c

Similar documents



988 CHEMOTHERAPY NOV. 1971

Fig. 1 Chemical structure of DL-8280

Fig.1 Chemical structure of BAY o 9867

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates


coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F

CHEMOTHERAPY

1272 CHEMOTHERAPY MAR. 1975

CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates

CHEMOTHERAPY

CHEMOTHERAPY NOV S. aureus, S. epidermidis, E. coli, K. pgeumoniae, E. cloacae, S. marcescens, P. mirabilis, Proteus, P. aeruginosa Inoculum siz

CHEMOTHERAPY

VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega




CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study


VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis


CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus

Staphylococcus sp. K.pneumoniae P.mirabilis C.freundii E. cloacae Serratia sp. P. aeruginosa ml, Enterococcus avium >100ƒÊg/ml

CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical Co.);

CHEMOTHERAPY SEPT. 1970

VOL.30 S-1 CHEMOTHERAPY Table 1 Antibacterial activity of CTT against standard strains Table 2 Antibacterial activity of CTT against standard strains

Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45)


VOL. 20 NO. 5 CHEMOTHERAPY Methoxy-4-sulfanilamidopyrimidine (OS-3376) Sulfadimethoxine (SDM) Table 1. In vitro antibacterial activities of OS-3

Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection

Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone

VOL. 23 NO. 3 CHEMOTHERAPY 1379 Table 1 Susceptibility of clinical isolated strains to Tobramycin


epidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia

Table1MIC of BAY o 9867 against standard strains

CHEMOTHERAPY APR Fig. 1 Chemical structure of cefotetan (CTT, YM09330)

VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains )

CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation

CHEMOTHERAPY APR Fig. 2 The inactivation of aminoglycoside antibiotics by PC-904 Fig. 3 Serum concentration of PC-904 (1) Fig. 4 Urinary recover


Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-

2108 CHEMOTHERAPY SEPT Table 1 Antimicrobial spectrum Fig. 1

CHEMOTHERAPY JUNE 1986


THE JAPANESE JOURNAL OF ANTIBIOTICS 48-8 Enterococcus avium 5Š, Corynebacterium xerosis 10Š, Corynebacterium pseudodiphtheriticum 10Š, Corynebacterium

Fig. 1 Chemical structure of KW-1070

VOL.47 NO.5 Table 1. Susceptibility distribution of Ĉ- lactams against clinical isolates of MRSA MRSA: rnethicillin- resistant Staphylococcus aureus





On the Wireless Beam of Short Electric Waves. (VII) (A New Electric Wave Projector.) By S. UDA, Member (Tohoku Imperial University.) Abstract. A new e


CHEMOTHERAPY DEC Table 1 Antibacterial spectra of T-1982, CTT, CMZ, CTX, CPZ and CEZ 106 CFU/ml Note: P; Peptococcus, S; Streptococcus, G; Gaffk


VOL. 21 NO. 2 CHEMOTHERAPY 395

CHEMOTHERAPY OCT Fig. 1 Chemical structure of CVA-K

VOL. 36 S-3 CHEMOTHERAPY 437

CHEMOTHERAPY Methicillin-resistant S.aureus(MRSA) coccus epidermidis 105 Streptococcus pyogenes E.faecali senterococcus avium Enterococcus faecium Str


CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX

Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad



pneumoniae 30, C. freundii 32, E. aerogenes 27, E. cloacae 32, P. mirabilis 31, P. vulgaris 34, M. morganii 32, S. marcescens 31, H. influenzae 27, P.

VOL.48 NO.7 lase negative staphylococci, Escherichia coli, Klebsiella spp., Citrobacter freundii, Enterobacter spp., indole-positive Proteus, Serratia

52-2.indb

Key Words: Klebsiella pneumoniae, CEP-AIS, MIC, "MBC", MIC of drugs in combination

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin


VOL.42 S-1


Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor

CHEMOTHERAPY Proteus mirabilis GN-79 Escherichia coli No. 35 Proteus vulgaris GN-76 Pseudomonas aeruginosa No. 11 Escherichia coli ML-1410 RGN-823 Kle

Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL Right Posted at the Inst

Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent

Kyoto University * Filipino Students in Japan and International Relations in the 1930s: An Aspect of Soft Power Policies in Imperial Japan


Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.

CHEMOTHERAPY APRIL 1992 Acinetobacter calcoaceticus Staphylococcus aureus, Escherichia coli P. aeruginosa E. eoli, Klebsiella pneumoniae Serratia marc


Table 1. Clinical Background of Studied Cases.

semen quality or those without WBC in semen. In the patients with azoospermia and normal FSH levels (normogonadotropic azzospermia), the antibody (IgG



untitled

Kekkaku Vol. 59, No8 STUDIES ON THE ORIGIN AND CLINICAL SIGNIFICANCE OF SMEAR-POSITIVE AND CULTURE-NEGATIVE TUBERCLE BACILLI Michio TSUKAMURA* and Har

CHEMOTHERAPY FEB Table 1 Background of volunteers



- 1 -

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood

Takio ICHITANI and Teruko HIGASHIKAWA: Germination of Aphanomyces iridis oospores on the basal medium for selective isolation with addition of bacteri

Transcription:

THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug. viable cell number was counted, the number decreased remarkably, then increasedrapidly number as the control. to the same (2) The some results were obtained with Escherichia coli when tested by the viable cell count method. 4. Therapeutic effect of rifampicin in experimental infections in mice. (1) In experimental infections with staphylococci, the therapeutic effect of rifampicin was about 2-times stronger than that of AB-PC. (2) In experimental infections with E. coli the therapeutic effect of rifampicin was about 1/10 weaker than that of AB-PC.

THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 in destruction of brucella. Proc. Soc. Exp. Biol. Med. 104(3) : 464 `467, July 1960. 22) RALSTON, D. J. & S.S. ELBERG : Intramonocytic destruction of brucella : Potentiating effect of glycine on intracellular lysozyme activity. J. Inf. Dis. 109(1) : 71 `80, July/Aug. 1961. 23) GOULD, G. W. ; D.L. GEORGALA & A.D. HITCHINS : Fltibrochrome-labelled lysozyme : Reagent for the detection of lysozyme substrate in cells. Nature 200(4904) : 385 `386, Oct. 26, 1963. 24) WILSON, L.A. & J.K. SPITZNAGEL : Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems. J. Bact. 96(4) : 1339 `1348, Oct. 1968. 25) BUKHARIN, O.V. & Z.M. YAKOVLEVA : Protective nonspecific action of lysozyme in the presence of infection. Antibiotiki 10(2) : 151 `156, Mar. 1965. cited in Excerpta Medica. 26) ANIKINA, T.P. : Effect of lysozyme on protective functions of micro and macrophages. Antibiotiki 12 (9) : 813 `817, Sept. 1967. cited in Chem. Abst. PROTECTIVE EFFECT OF HUMAN PLACENTAL LYSOZYME ON EXPERIMENTAL INFECTION IN MICE INDUCED BY CLOSRIDIUM TETANI, STAPHYLOCOCCUS AUREUS OR DIPLOCOCCUS PNEUMONIAE TADAKAZU SUYAMA, YOSHIGORO OGURO, TAKUJI DOI and KEN-ICHI IZAKA The Research Laboratory of The Green Cross Corporation, 1/3 Gamau-cho, Joto-ku, Osaka, Japan Abstract Antibacterial action of human placental lysozyme alone or in combination with penicillins was studied in vitro and in vivo experiments. In vitro experimentals, the lysozyme was found to inhibit the growth of Bacillus subtilis at the concentration of 30 mcg/ml of medium, but not to inhibit the growth of Clostridium tetani, Staphylococcus aureus or Diplococcus pneumoniae even at the concentration of 1,000 mcg/ml of medium. These inhibitory activities of placental lysozyme were comparable to those of egg white lysozyme. Combined antibacterial effect of the lysozyme with penicillins was noticed in S. aureus and D. pneumoniae, but in C. tetani. In vivo studies, however, preliminary administration of placental lysozyme alone or in combination with penicillin G exerted a marked prolongation on survival time of mice infected by C. tetani Harvard, suggesting a protective effect against tetanus infections, although the lysozyme preparation did not show any antitoxin action both in vitro and in vivo experiments. In order to control the experimental tetanus infection in mice with lysozyme it seemed necessary to inject intramuscularly daily dose of 50 to 100 mcg/mouse for 7 days (3 doses before and 4 doses after infection). Staphylococcal infection in mice was also protected by intramuscular administration of the lysozyme alone. This effect was potentiated by combined use with penicillins. In case of pneumococcal infection the lysozyme alone did not show significant prolongation on survival time of mice, but it potentiated the protective effect of penicillins against this experimental infections.

THE JAPANESE' JOURNAL OF ANTIBIOTICS XXII-4 3) TURK, D.C.& J.R.MAY:Haemophilus infiuenzae. Its clinical importance. p.44 `47, English Universities Press, London,1967. 4) HOLDAWAY, M.D. & D.C.TURK: Capsulated Haemophilus infiuenzae and respiratory-tract disease. Lancet 1967-1: 358 360, 1967. 5) TURK, D.C. & J.R.MAY:Haemophilus infiuenzae. Its clinical importance. p.39-43, English Universities Press, London, 1967. 6) TURK, D.C. & J.R.MAY: Haemophilus infiuenzae. Its clinical importance. p.15, p.53, English Universities Press, London, 1967. 7) MAY,J.R.:Ampicillin in the therapy of chronic bronchitis. Postgrad. Med. J. 40(12) : 193-197, Dec. 1964. 8) TURK, D.C. & J.R.MAY:Haemophilus infiuenzae. Its clinical importance. p.73, English Universities Press, London, 1967. 9) UEHARA, S.:The role of Haemophilus infiuenzae in recurrent bronchitis in infantand children. XII. International Congress of Pediatrics. Dec. 1968.

THE,JAPANESE, JOURNAL OF ANTIBIOTICS ' Aug.

THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug.19 69

THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4

322 THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug. 3) ABRAHAM, E. P & E. S. DUTHIE: Effect of ph of the medium on activity of streptomycin and penicillin and other chemotherapeutic substances. Lancet 1946-1: 455-459, 1946. 4) MOU, T. W.: Effect of urine ph on the antibacterial activity of antibiotics and chemotherapeutic agents. J. Urol. 87(6): 978-987, Dec. 1962. 5) SABATH, L. D., D. A. GERSTEIN, P. B. LODER & M. FINLAND: Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization. J. Lab. & Clin. Med. 72 (6): 916-923, Dec. 1968. 6) EAGLE, H., M. LEUY & R. FLEISCHMAN: The effect of the ph of the medium on the antibacterial action of penicillin, streptomycin, chloramphenicol, terramycin, and bacitracin. Antibiot. & Chemoth. 2(11): 563,-575, Nov. 1952.

Aug. THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 323

324 THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug.

Aug, THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 325

THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug.

Aug. THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 327

328 THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug,

Aug. THE JAPANESE JOURNAL OF ANTIBIOTICS XXII -4 329

330 THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug.1 969

Aug. THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 331

332 THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug.1 969

Aug. THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 333

334 THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug.